Recipharm will publish its interim report for January-September 2016 on 10 November at 07:45 am CET.
The company invites investors, analysts and media to a web conference (in English) on 10 November at 10:00 am CET, where CEO Thomas Eldered and CFO Björn Westberg will present and comment on the report as well as answer questions.
The report will be available on Recipharm’s website www.recipharm.com/investor-relations from 07:4
To participate in the web conference, please use the below link:
http://edge.media-server.com/m/p/prxpzamq
Questions may be submitted by dialing below telephone numbers or by typing them in the Q&A box during the conference. If you don’t wish to ask questions by telephone you only need to participate through the link above.
From Sweden: + 46 8 505 963 06
From Denmark: + 45 354 45597
From Finland: + 358 9 8171 0317
From France: + 33 29092 0977
From Germany: + 49 30 211 510 067
From India: + 91 226187 51 03
From Italy: + 39 2 3604 67 98
From Norway: + 47 235 00 559
From Portugal: + 35 210 609104
From Spain: + 34 911 143 608
From Switzerland: + 41 44 5800083
From the UK: + 44 203 139 48 30
From the USA: + 1 718 873 90 77
Pin code for participants:
44823539#
For more information, please contact:
Björn Westberg, CFO, +46 8 602 46 20, ir@recipharm.com
Recipharm AB (publ)
Corporate identity number 556498-8425
Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52 00, Fax 46 8 81 87 03
www.recipharm.com
